Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials Open access logo PDF logo

Vandenberghe R, Rinne JO, Boada M, Katayama S, Scheltens P, Vellas B, Tuchman M, Gass A, Fiebach JB, Hill D, Lobello K, Li D, McRae T, Lucas P, Evans I, Booth K, Luscan G, Wyman BT, Hua LS, Yang LF, Brashear HR, Black RS

Alzheimer's Research & Therapy Volume 8, Issue 1, DOI: 10.1186/s13195-016-0189-7

  • 3 tweets
  • 1 news
  • 60 Mendeley readers


Generating chart...

Tweet geographics

By country: 1

Unknown: 2

Generating map...


Tweets: 3

Retweets: 0

      Site data sourced from and CSC (VIRTA)